These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29920241)

  • 21. Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression.
    Zakraoui O; Marcinkiewicz C; Aloui Z; Othman H; Grépin R; Haoues M; Essafi M; Srairi-Abid N; Gasmi A; Karoui H; Pagès G; Essafi-Benkhadir K
    Mol Carcinog; 2017 Jan; 56(1):18-35. PubMed ID: 26824338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.
    Zhang J; Li C; Sun L; Sun D; Zhao T
    Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37921068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.
    Ruiz de Porras V; Bystrup S; Martínez-Cardús A; Pluvinet R; Sumoy L; Howells L; James MI; Iwuji C; Manzano JL; Layos L; Bugés C; Abad A; Martínez-Balibrea E
    Sci Rep; 2016 Apr; 6():24675. PubMed ID: 27091625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
    Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Acid Ceramidase Inhibits Glioblastoma Cell Migration through Decreased AKT Signaling.
    Hawkins CC; Jones AB; Gordon ER; Williford SE; Harsh Y; Ziebro JK; Landis CJ; Gc S; Crossman DK; Cooper SJ; Ramanadham S; Doan N; Hjelmeland AB
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
    Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
    Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
    Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
    Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin β-D-glucuronide exhibits anti-tumor effects on oxaliplatin-resistant colon cancer with less toxicity in vivo.
    Ozawa-Umeta H; Kishimoto A; Imaizumi A; Hashimoto T; Asakura T; Kakeya H; Kanai M
    Cancer Sci; 2020 May; 111(5):1785-1793. PubMed ID: 32163218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis.
    Cheng C; Xie Z; Li Y; Wang J; Qin C; Zhang Y
    Biomed Pharmacother; 2018 Dec; 108():194-200. PubMed ID: 30219676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue transglutaminase-mediated chemoresistance in cancer cells.
    Verma A; Mehta K
    Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity.
    Long X; Wong CC; Tong L; Chu ESH; Ho Szeto C; Go MYY; Coker OO; Chan AWH; Chan FKL; Sung JJY; Yu J
    Nat Microbiol; 2019 Dec; 4(12):2319-2330. PubMed ID: 31501538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expression.
    Li JM; Jiang GM; Zhao L; Yang F; Yuan WQ; Wang H; Luo YQ
    Oncol Rep; 2019 Nov; 42(5):1725-1734. PubMed ID: 31436301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance.
    Su JM; Gui L; Zhou YP; Zha XL
    World J Gastroenterol; 2002 Aug; 8(4):613-8. PubMed ID: 12174366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Butyrate-treated colonic Caco-2 cells exhibit defective integrin-mediated signaling together with increased apoptosis and differentiation.
    Lévy P; Robin H; Bertrand F; Kornprobst M; Capeau J
    J Cell Physiol; 2003 Dec; 197(3):336-47. PubMed ID: 14566963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Dicer in regulating oxaliplatin resistance of colon cancer cells.
    Lai HH; Lin LJ; Hung LY; Chen PS
    Biochem Biophys Res Commun; 2018 Nov; 506(1):87-93. PubMed ID: 30336979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β3GnT8 regulates oxaliplatin resistance by altering integrin β1 glycosylation in colon cancer cells.
    Shen L; Dong X; Wang Y; Qiu L; Peng F; Luo Z
    Oncol Rep; 2018 Apr; 39(4):2006-2014. PubMed ID: 29393491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
    Hua H; Chen W; Shen L; Sheng Q; Teng L
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2.
    Khare S; Holgren C; Samarel AM
    Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1100-12. PubMed ID: 16920701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer.
    Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K
    J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis.
    White-Gilbertson S; Lu P; Norris JS; Voelkel-Johnson C
    J Lipid Res; 2019 Jul; 60(7):1225-1235. PubMed ID: 30988134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.